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Mutations were targeted to the Hprt locus in murine embryonic stem ceUs by using sequence replacement 
vectors. When the vector was designed such that the mutated sequences were 8anked on both sides by several 
kilobases of DNA homologous to the target locus, replacement of chromosomal sequences with the exogenous 
DNA occurred with precision. If, on the other hand, the target-homologous DNA on one arm of the vector was 
reduced to below 1 kb in length, the fidelity of recombination was diminished. 
Gene targeting in mouse embryo-derived stem (ES) cells 
(22) provides the means to introduce specific mutations into 
the mouse genome. Analysis of the phenotypes of mice 
carrying such mutations has provided insight into the bio-
logical roles of a number of genes whose functions had 
previously been only a matter of speculation (3, 4, 8-11, 13, 
15-18, 20, 23-25). 
The first step in the gene targeting protocol is to mutate, in 
vitro, a cloned copy of the gene of interest. The mutated 
gene, carried on a targeting vector, is then introduced into 
ES cells, some fraction of which incorporates the exogenous 
sequences via homologous recombination. The most com-
monly used targeting vector is the replacement vector, 
which contains a linear array of wild-type genomic DNA on 
both sides of the mutated sequence (22). The vector is 
thought to pair via shared homology with its chromosomal 
counterpart, and subsequent homologous recombination-
either a double-reciprocal exchange surrounding the muta-
tion or a gene conversion event-replaces the genomic 
sequences with sequences from the targeting vector. 
The capacity to create predetermined genomic alterations 
is thus dependent upon the precision of the recombination 
reaction. Although nonspecific mutagenesis and genomic 
rearrangements have been shown to accompany homologous 
recombination (2, 5, 21), such events have generally not 
been viewed as problematic because of their low frequency 
of occurrence. Of over 20 animals generated through re-
placement vector-mediated recombination, only one con-
tained a recombinant locus which deviated from that ex-
pected (23). In this case, a dimer of the targeting vector was 
used as one of the reactants, and a tandem duplication of 
mutant vector sequences replaced the endogenous locus. 
The general assumption that replacement vector-mediated 
recombination proceeds with high fidelity has recently been 
challenged (7). This particular examination of gene targeting 
at the Hprt locus in murine ES cells revealed that fewer than 
5% of the recombinants were the result of simple legitimate 
replacement reactions. The vast majority of the events 
analyzed in this study were accompanied either by vector 
rearrangements prior to recombination or by genomic rear-
rangements presumably induced during recombination. One 
implication from this study is that replacement vector-
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mediated homologous recombination is inherently inaccu-
rate. 
The discrepancies between this latter study and the nu-
merous other published reports of legitimate gene replace-
ment prompted us to scrutinize potential differences in the 
experimental protocols of the various investigations. One 
untested variable has been in the design of the replacement 
vectors, specifically, the lengths of the genome-homologous 
DNA sequences between the mutation and the ends of the 
vector. To determine whether the fidelity of homologous 
recombination could be influenced by the amount of homol-
ogy flanking the mutation, we examined the products of gene 
targeting under conditions in which this length was varied. 
In this report, we show that replacement vector-mediated 
recombination is not inherently inaccurate. When the re-
placement vector is designed such that the desired mutation 
is flanked on both sides by several kilobases of DNA 
homologous to the target locus, gene replacement proceeds 
with fidelity. If, on the other hand, the mutation is flanked on 
one side by less than 1 kb of target-homologous DNA, 
abortive recombination can occur. 
MATERIALS AND METHODS 
Vectors and cell lines. Construction of plasmid 
pHPRT9.6oeo has been described elsewhere (22). The ES 
cell line, CC1.2 (1), was derived by E. Robertson. Transfor-
mation of ES cells by electroporation and selection condi-
tions for gene replacement events by using 6-thioguanine 
(6-TG) and G418 have been published previously (22). 
DNA purification and analysis. ES cell lines resistant to 
6-TG and G418 were grown to conftuence on a 60-mm plate. 
The cells were harvested by centrifugation, resuspended in 
1.5 ml of lysis buffer (10 mM EDTA, 100 mM NaCI, 1.5% 
sodium dodecyl sulfate, 20 mM Tris-HCI [pH 7.8]), and 
digested with protease K (0.2 mglml; Beckman) at 37°C for 2 
h. DNA was purified from each cell line by the following 
salting-out protocol, generously provided by Brian Stanton 
(National Cancer Institute, Frederick, Md.). Five hundred 
microliters of the cell extract was mixed vigorously with 250 
ILl of saturated NaCI; after 10 min on ice, the mixture was 
centrifuged at 3,000 x g in a microcentrifuge; 600 ILl of the 
supernatant was removed, and the DNA was precipitated 
with 2 volumes of ethanol; the DNA was removed with a 
glass rod and resuspended in 150 ILl of a 10 mM Tris-HCI-l 
mM EDT A (pH 8.0) solution. 
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FIG. 1. Gene targeting vectors. Construction of plasmid pHPRT 
9.6neo has been described elsewhere (22). To generate the targeting 
vector, pRV9.1, pHPRT9.6neo was digested with BglII; to generate 
pRV6.8, pHPRT9.6neo was digested with HindIII. B, BglII; H, 
HindIII. Narrow lines represent introns and 3' noncoding regions of 
the murine Hprt locus; solid boxes represent Hprt exons, numbered 
as defined by Melton et al. (14); striped boxes represent the Neor 
gene from plasmid pMC1Neo; open box represents sequences from 
plasmid pUC9. 
Five micrograms of purified DNA from each cell line was 
digested with restriction endonuclease and analyzed by 
Southern transfer analysis as described previously (22). 
Hybridization probes were as follows. Probe a is a 500-bp 
Sphl-Bg/II fragment from intron 5, immediately 5' to the end 
of sequences in the targeting vectors; probe b is a 1-kb 
BstEII-Seal fragment extending from intron 6 to the middle 
of exon 8, containing sequences present on both targeting 
vectors; probe c is a 300-bp Hindlll fragment containing 
sequences outside the Hprt locus, beginning 200 bp 3' from 
the end of the vector, pRV9.1. 
RESULTS 
Experimental design. Mutations were targeted to exon 8 of 
the murine Hprt gene. Cells harboring mutations were first 
identified by virtue of their resistance to G418 and 6-TG. 
Cells resistant to both G418 and 6-TG were then screened by 
Southern transfer analysis. Such analysis not only confirms 
the presence of the targeted mutation but can detect rear-
rangements in genomic sequences resulting from inappropri-
ate recombination. 
The targeting vectors used in these experiments are de-
picted in Fig. 1. They are derived from plasmid 
pHPRT9.6nco, which contains 9.6 kb of murine Hprt DNA, 
interrupted in exon 8 by the bacterial Neo r gene. The NeD' 
gene not only disrupts the coding region of the Hprt gene but 
serves as a positive selectable marker to identify cells 
transfected with the targeting vector. Two replacement 
vectors were derived from this plasmid by different restric-
tion endonuclease digestions. Digestion with Bg/II produces 
pRV9.1, which contains the mutated exon 8 flanked on the 5' 
end by 6.1 kb of Hprt sequences and on the 3' end by 3.0 kb 
of Hprt sequences. The other vector, pRV6.8, is released by 
digestion with HindlII and contains the same 6.1 kb of 5' 
flanking DNA found in pRV9.1 but only 0.7 kb of DNA 3' to 
the Neor gene insertion. 
Following digestion of the plasmid with the appropriate 
enzyme, DNA was introduced into ES cells by electropora-
tion. Colonies resistant to both G418 and 6-TG, derived from 
four separate e1ectroporation experiments, were isolated, 
MOL. CELL. BIOL. 
and their DNA was analyzed by Southern transfer. DNA 
was digested with two different restriction endonucleases 
and probed with three different Hprt probes designed to 
detect rearrangements of both internal and flanking se-
quences. The targeting frequency, expressed as the ratio of 
the number of G418r, 6-TGr colonies to the number of cells 
surviving electroporation, was 1 x 10-5 for pRV9.1 and 4 x 
10-6 for pRV6.8. 
pRV9.1-induced recombinants are of predictable structure. 
Eighteen Neor, 6-TGr colonies resulting from transfection 
with pRV9.1 were chosen for analysis by Southern transfer. 
Figure 2E shows restriction maps of the wild-type genomic 
Hprt locus and the same locus replaced with pRV9.1 se-
quences. The 9.1-kb EeoRI fragment containing the wild-
type Hprt exon 8 can be detected when DNA from the 
parental ES line, CC1.2, is digested with EeoRI and probed 
with either sequences flanking the vector (probe a) or an 
internal fragment (probe b). Insertion of the Neor gene in 
exon 8 introduces an additional EeoRI site such that probes 
a and b are predicted to hybridize to a fragment 8.1 kb in 
length. All 18 cell lines targeted with pRV9.1 show only the 
predicted 8.1-kb fragment, implying that no major rearrange-
ments 5' to the Neor gene insertion were generated by the 
targeting reaction (Fig. 2A and B). (The fainter, 9.1-kb band 
seen in all lanes is from the wild-type Hprt gene present in 
the feeder cells upon which the ES cells are grown.) 
To analyze sequences 3' to the Neor gene insertion, DNA 
from the same 18 cell lines was digested with Xbal. An 
8.4-kb Xbal fragment is detected in wild-type CC1.2 DNA 
hybridized to both probe b and probe c, a probe isolated 
from sequences located 3' to sequences in the targeting 
vector (Fig. 2C and D). Targeting of the 1-kb Neor gene to 
exon 8 should increase the length of this Xbal fragment by 1 
kb. In all cell lines targeted by pRV9.1, only a 9.4-kb Xbal 
fragment is detected by either probe b or probe c. This 
finding suggests that rearrangements at the 3' end of the Hprt 
gene did not occur in any of the 18 cell lines examined. 
pRV6.8 can induce rearrangements. The precision of re-
combination obtained with pRV9.1, although consistent with 
our previous results, is in striking contrast to a recent study 
that showed rearrangements in over 95% of replacement 
vector-induced recombinant cells (7). The replacement vec-
tor used by Hasty et al. (7) is similar in design to pRV9.1 but 
contains 2 kb less homology 3' to the Neor gene insertion 
than does pRV9.1. To determine whether this difference in 
vector design might be responsible for the difference in 
results, we reduced the amount of contiguous homology at 
the terminus of the targeting vector. The vector, pRV6.8, 
contains the same 6.1 kb of homology 5' to the Neor gene 
insertion found in pRV9.1 but has only 0.7 kb of homology 3' 
to the insertion. Eighteen G418r, 6-TGr clones resulting from 
transfection with pRV6.8 were analyzed by Southern trans-
fer analysis, using the enzymes and probes described for the 
analysis of pRV9.1-transformed cells. Analysis of sequences 
5' to the Neor gene by EeoRI digestion and hybridization to 
probes a and b clearly shows two cell lines containing a 
fragment deviating from the predicted 8.1-kb length (lines 2m 
and 2n; Fig. 3A and B). Analysis of the 3' end with Xbal 
digestion and hybridization to probe b reveals three addi-
tional cell lines (2a, 2b, and 2c) with unpredicted structures 
at the Hprt locus (Fig. 3C). 
Rearrangements can result from vector concatemerization. 
The structures of three of the aberrant pRV6.8-induced 
recombinants can be deduced from the restriction endonu-
clease digestions shown in Fig. 3. Cell lines 2a, 2b, and 2c all 
contain a tandem duplication of Hprt sequences present on 
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FIG. 2. Gene targeting with pRV9.1. (A to D) Southern transfer 
analysis. DNA was extracted from 18 G418r , 6-TG r cell lines (la 
through Ir) transfected with plasmid pRV9.1 and from the parental 
ES cell line, CC1.2. A 5-l1og aliquot from each cell line was digested 
with either EcoRI (A and B) or XbaI (C and D), electrophoresed 
through 0.7% agarose, and transferred to a nitrocellulose mem-
brane. The membranes were then hybridized to random-primed, 
32P-labeled probes (Pharmacia) (described in Materials and Meth-
ods). Numbers to the right of each panel indicate the sizes of the 
labeled fragments in kilobases. (E) Restriction endonuclease maps. 
The upper map represents wild-type Hprt DNA from the parental 
cell line, CC1.2; the lower map depicts the targeted loci from the 
hprt- cell lines analyzed by Southern transfer. Thin lines represent 
intron and 3' flanking sequences; numbered boxes represent exons; 
striped box represents the Neor gene within exon 8; open boxes 
represent positions of the probes. E, EcoRI; X, Xbal. Origins of the 
fragments seen in panels A to D are indicated beneath each map. 
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the targeting vector. This duplicated structure is distin-
guished by a 5-kb XbaI fragment and an 8.9-kb EcoRI 
fragment that hybridize to probe b. (The 8.9-kb EcoRI 
fragment is masked somewhat by the 9.1-kb fragment from 
feeder cell DNA.) Only the 5' copy of the duplication, 
however, contains the Neor gene insertion in exon 8, verified 
by an 8.4-kb, wild-type XbaI fragment detected by probe c, 
the 3' flanking probe. The presence of the repeat in the 
genome is presumably the result of concatemerization of the 
targeting vector prior to recombination, followed by a gene 
replacement reaction with crossover points as depicted in 
Fig. 3E. Although uncommon, similar reactions have been 
reported previously (6, 19, 23). The structures of the rear-
ranged Hprt locus in cell lines 2m and 2n are more complex 
and have not been fully determined. 
DISCUSSION 
We have shown that gene targeting via a gene replacement 
reaction proceeds in a predictable manner, provided that 
sufficient homology flanks the mutated sequence. Following 
targeted mutagenesis of the Hprt locus with the vector 
pRV9.1, all 18 analyzed recombinants were shown to con-
tain a single copy of the Hprt locus, disrupted in exon 8 by 
the Neor gene. Furthermore, analysis of regions both 5' and 
3' to the replaced sequences failed to detect rearrangements 
of adjacent DNA. The fidelity of the replacement reaction 
could be altered experimentally, however, by reducing the 
length of end-terminal homology on the targeting vector. 
When the vector pRV6.8 was used as a reactant, for exam-
ple, 5 of 18 recombinants showed an unexpected structure of 
the targeted locus. Of these, at least 3 contained a structure 
consistent with the replacement of genomic sequences with 
sequences from a concatemerized targeting vector. 
The difference in recombination fidelity between pRV9.1 
and pRV6.8 corresponds to a 2.3-kb difference in Hprt 
homology on one arm of the targeting vector. It is likely that 
the reduction in arm length rather than a reduction in the 
amount of absolute homology between the targeting vector 
and the target locus is responsible for the rearrangements 
induced by pRV6.8. In experiments similar to those pre-
sented here, we have examined the recombinant products 
formed by replacement vectors sharing as little as 5.4 kb of 
total homology with the target locus. When this homology 
was distributed equally on the two arms of the replacement 
vectors, no rearrangements in the recombinant products 
were detected (22; unpublished results). 
The minimum length of homology on both arms of the 
targeting vector necessary for accurate gene replacement 
may reflect a requirement for stable pairing between the 
vector and its target. Stability can also be realized by the 
pairing of a concatemerized vector, as shown in Fig. 3E. 
Vector concatemerization is presumably the result of extra-
chromosomal recombination occurring prior to the gene 
targeting reaction. Under similar experimental conditions, 
concatemerization of the two vectors, pRV6.8 and pRV9.1, 
would be expected to occur at a similar frequency. How-
ever, because of minimum homology restrictions, a multimer 
of the shorter vector, pRV6.8, may show an increased 
recombinogenic advantage with respect to the pRV6.8 
monomer, thus increasing the proportion of duplication 
events following transfection with this vector. The depres-
sion of recombinational fidelity caused by a reduced arm 
length may be compounded if there is also sequence heter-
ology between the vector arm and its target. Such heterolo-
gies can be encountered when vector DNA is derived from a 
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FIG. 3. Gene targeting with pRV6.8. (A to D) Southern transfer 
analysis. DNA was extracted from 18 G418', 6-TG' cell lines (2a 
through 2r) transfected with pRV6.8. Analysis was performed as 
described in the legend to Fig. 2. (E) Duplication of the targeting 
vector. The upper map represents the head-to-tail dimerization of 
the HindIII-linearized vector pRV6.8; the lower map represents the 
chromosomal Hprt locus; diagonal lines highlight potential recom-
bination sites. Thin horizontal lines represent introns and 3' flanking 
sequences; numbered boxes represent Hprt exons; striped boxes 
represent the Neo' gene. H, HindIII. (F) Hprt locus in cell lines 2a, 
2b, and 2c, resulting from recombination with a dimerized targeting 
vector. Positions of the probes used in the Southern transfer 
analysis are indicated by open boxes, and the origins of the 
fragments labeled in panels A to D are indicated beneath the map. 
mouse strain nonisogenic with that of the target cell line and 
can vary in degree along the genome. It is possible that such 
heterology is responsible for the fact that Hasty et al. (7) find 
an even greater number of rearrangements (95%) when 
targeting Hprt exon 3 than we report for exon 8 (30%). 
Previous observations of such rearranged structures have 
led to the suggestion (7) that alternative vector designs, such 
as sequence insertion vectors (22), may be preferable to 
sequence replacement vectors in performing targeted gene 
modification. Insertion vectors are derived from circular 
DNA by the introduction of a double-strand break within a 
region of homology shared between the vector and the 
genomic target. This breakpoint can define the site of a 
recombination reaction which results in the insertion of the 
entire vector into the genome. Although replacement and 
insertion vectors are equally efficient (22), insertion vectors 
cause the formation of tandem duplications. Such duplica-
tions are unstable and may undergo intrachromosomal re-
combination, resulting in elimination of the vector sequences 
and reversion of the locus to its wild-type state. Although 
these reversions may occur at a low frequency (one in 106 
cells [4a)1' a mouse derived from such cells (and containing 
over 10 total cells) is expected to experience numerous 
somatic reversions. The phenotypes of a population of such 
mosaic animals might vary dramatically. Therefore, if the 
objective of the targeted modification is to create in a single 
step a null mutation at a specific locus, the use of an insertion 
vector in lieu of a replacement vector is not a viable option. 
Cells containing mutations introduced by replacement vec-
tors, however, do not suffer from such genetic instability, 
and our results reaffirm the fact that replacement vectors are 
quite capable of targeting predetermined mutations to the 
genome of ES cells. 
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